Experiments in vitro further confirmed that miR-182 can promote the metastasis of HCC cell lines and down-regulate MTSS1, which further elucidate the metastatic mechanism of HCC and may suggest novel findings for targeted treatment. This evidence concerns the gene MTSS1 and hepatocellular carcinoma.